4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001062993-25-001237
Chief Executive Officer sold 13,392 shares at an average $77.29 ($1,035,013)
- Chief Executive Officer acquired 13,392 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelderman Kim Chief Executive Officer | 2025-01-27 | Option exercise | +13,392 | $37.70 | $504,878 | 52,396 | D |
| Kelderman Kim Chief Executive Officer | 2025-01-27 | Sale | −11,731 | $77.19 | $905,533 | 40,665 | D |
| Kelderman Kim Chief Executive Officer | 2025-01-27 | Sale | −1,661 | $77.95 | $129,480 | 39,004 | D |
| Derivatives | |||||||
| Kelderman Kim Chief Executive Officer | 2025-01-27 | Option exercise · Stock Option (Right to Buy) | −13,392 | 0 | D | ||
| Open-market sales · 13,392 sh · avg $77.29 · $1,035,013 | |||||||
Loading xslF345X05/form4.xml…